Kennedy Capital Management’s Mesa Laboratories MLAB Stock Holding History
Bought
Maintained
Sold
Other funds holding MLAB
LPP
RIM
Kennedy Capital Management's MLAB Position: Q2 2026 in Review
Kennedy Capital Management reduced its Mesa Laboratories (MLAB) stake by 2.8% in Q2 2026, selling an estimated $407K and leaving 138,301 shares worth $13.8M. The position accounts for 0.24% of the portfolio, ranked #142.
Kennedy Capital Management first reported a position in MLAB in Q4 2022 and has held it in 15 quarters since. 160 funds tracked by Wall St. Rank hold MLAB as of Q2 2026.
- Kennedy Capital Management held 138,301 shares of Mesa Laboratories worth $13.8M as of Q2 2026.
- Kennedy Capital Management sold 4,042 Mesa Laboratories shares in Q2 2026, an estimated $407K.
- Mesa Laboratories made up 0.24% of Kennedy Capital Management's portfolio in Q2 2026, its #142 holding.
- Kennedy Capital Management first reported a position in Mesa Laboratories in Q4 2022 and has held it in 15 quarters since.
- 160 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2026.
Based on Kennedy Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.